|
1
|
Zucca E, Arcaini L, Buske C, Johnson PW,
Ponzoni M, Raderer M, Salar A, Stamatopoulos K, Thieblemont C,
Wotherspoon A, et al: Marginal zone lymphomas: ESMO Clinical
Practice Guidelines for diagnosis, treatment and follow-up. Ann
Oncol. 31:17–29. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
http://Uptodate.comsimpleUptodate.com accessed on
19.05.2020.
|
|
3
|
Feldman M and Lawrence JB: Sleisenger and
Fordtran's gastrointestinal and liver disease. 10th edition,
Philadelphia, Elsevier Saunders, pp473-477, 2015.
|
|
4
|
Chan AO, Chu KM, Yuen ST, Leung SY, Lam SK
and Wong J: Synchronous gastric adenocarcinoma and
mucosa-associated lymphoid tissue lymphoma in association with
Helicobacter pylori infection: Comparing reported cases
between the East and West. Am J Gastroenterol. 96:1922–1924.
2001.PubMed/NCBI
|
|
5
|
Gisbert JP and Calvet X: Common
misconceptions in the management of Helicobacter
pylori-associated gastric MALT- lymphoma. Aliment Pharmacol
Ther. 34:1047–1062. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Podolsky DK, Camilleri M, Fitz G, Kalloo
AN and Shanahan F (eds): Yamada's Textbook of Gastroenterology. 6th
edition, Sussex, Wiley Blackwell, 1123, 1332, 1341, 1574, 2016.
|
|
7
|
Bacon CM, Ming-Qing D and Dogan A:
Mucosa-associated lymphoid tissue (MALT) lymphoma: A practical
guide for pathologists. J Clin Pathol. 60:361–72. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Isaacson PG, Berger F, Muller-Hermelink
HK, Nathwani BN, Piris MA, Swerdlow SH, et al: Extranodal marginal
zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT
lymphoma). In: Jaffe ES, Harris NL, Stein H, Vardiman JW, (eds).
World Health Organization classification of tumours, Tumours of
haematopoietic and lymphoid tissues. Lyon, IARC Press, pp157-160,
2001.
|
|
9
|
Ruskoné-Fourmestraux A, Dragosics B,
Morgner A, Wotherspoon A and de Jong D: Paris staging system for
primary gastrointestinal lymphomas. Gut. 52:912–913.
2003.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Musshoff K: Clinical staging
classification of non-Hodgkin's lymphomas (author's transl).
Strahlentherapie. 153:218–221. 1977.PubMed/NCBI(In German).
|
|
11
|
Stathis A, Chini C, Bertoni F, Proserpio
I, Capella C, Mazzucchelli L, Pedrinis E, Cavalli F, Pinotti G and
Zucca E: Long-term outcome following Helicobacter pylori
eradication in a retrospective study of 105 patients with localized
gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol.
20:1086–1093. 2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hong SS, Jung HY, Choi KD, Song HJ, Lee
GH, Oh TH, Jo JY, Kim KJ, Byeon JS, Myung SJ, et al: A prospective
analysis of low-grade gastric malt lymphoma after Helicobacter
pylori eradication. Helicobacter. 11:569–573. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Raderer M, Streubel B, Wohrer S, Häfner M
and Chott A: Successful antibiotic treatment of Helicobacter
pylori negative gastric mucosa associated lymphoid tissue
lymphomas. Gut. 55:616–618. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Park HS, Kim YJ, Yang WI, Suh CO and Lee
YC: Treatment outcome of localized Helicobacter
pylori-negative low-grade gastric MALT lymphoma. World J
Gastroenterol. 16:2158–2162. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Negrut N, Khan SA, Bungau S, Zaha DC, Anca
CAR, Bratu O, Diaconu CC and Ionita-Radu F: Diagnostic challenges
in gastrointestinal infections. Rom J Mil Med. CXXIII:83–90.
2020.
|
|
16
|
Ferreri AJ, Freschi M, Dell'Oro S, Viale
E, Villa E and Ponzoni M: Prognostic significance of the
histopathologic recognition of low- and high-grade components in
stage I-II B-cell gastric lymphomas. Am J Surg Pathol. 25:95–102.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hatakeyama M: Helicobacter pylori
CagA - a bacterial intruder conspiring gastric carcinogenesis. Int
J Cancer. 119:1217–1223. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Oliveira MJ, Costa AM, Costa AC, Ferreira
RM, Sampaio P, Machado JC, Seruca R, Mareel M and Figueiredo C:
CagA associates with c-Met, E-cadherin, and p120-catenin in a
multiproteic complex that suppresses Helicobacter
pylori-induced cell-invasive phenotype. J Infect Dis.
200:745–755. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Umehara S, Higashi H, Ohnishi N, Asaka M
and Hatakeyama M: Effects of Helicobacter pylori CagA
protein on the growth and survival of B lymphocytes, the origin of
MALT lymphoma. Oncogene. 22:8337–8342. 2003.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yokoyama K, Higashi H, Ishikawa S, Fujii
Y, Kondo S, Kato H, Azuma T, Wada A, Hirayama T, Aburatani H and
Hatakeyama M: Functional antagonism between Helicobacter
pylori CagA and vacuolating toxin VacA in control of the NFAT
signaling pathway in gastric epithelial cells. Proc Natl Acad Sci
USA. 102:9661–9666. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jones KR, Whitmire JM and Merrell SD: A
tale of two toxins: Helicobacter pylori CagA and VacA
modulate host pathways that impact disease. Front Microbiol.
1(115)2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Dierlamm J, Baens M, Wlodarska I,
Stefanova-Ouzounova M, Hernandez JM, Hossfeld DK, De Wolf-Peeters
C, Hagemeijer A, Van den Berghe H and Marynen P: The apoptosis
inhibitor gene API2 and a novel 18q gene, MLT, are recurrently
rearranged in the t(11;18)(q21;q21) with mucosa-associated lymphoid
tissue lymphomas. Blood. 93:3601–3609. 1999.PubMed/NCBI
|
|
23
|
Takada S, Yoshino T, Taniwaki M, Nakamura
N, Nakamine H, Oshima K, Sadahira Y, Inagaki H, Oshima K and
Tadaatsu A: Involvement of the chromosomal translocation t(11;18)
in some MALT lymphomas and diffuse large B-cell lymphomas of the
ocular adnexa: Evidence from multiplex rTP chain reaction and
fluorescence in situ hybridization on using formalin-fixed,
paraffin-embedded specimens. Mod Pathol. 16:445–452.
2003.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kasper DL, Hauser S, Jameson L, Fauci AS
and Longo DL: Harrison's principles of internal medicine. 19th
edition Vol. 2. N.p: McGraw-Hill Education 2 vols. 697: 702-703,
1038-1042, 2015.
|
|
25
|
Wotherspoon AC: A critical review of the
effect of Helicobacter pylori eradication on gastric MALT
lymphoma. Curr Gastroenterol Rep. 2:494–498. 2000.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Malfertheiner P, Megraud F, O'Morain CA,
Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton
J, Graham DY, et al: Management of Helicobacter pylori
infection - the Maastricht V/Florence consensus report. Gut.
66:6–30. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Asenjo LM and Gisbert JP: Prevalence of
Helicobacter pylori infection in gastric MALT lymphoma: A
systematic review. Rev Esp Enferm Dig. 99:398–404. 2007.PubMed/NCBI View Article : Google Scholar : (In Spanish).
|
|
28
|
Iftimie G, Pantea Stoian A, Socea B,
Motofei I, Marcu D, Costache RS and Diaconu C: Complications of
systemic lupus erythematosus: A review. Rom J Mil Med. CXXI:9–15.
2018.
|
|
29
|
Chiang IP, Wang HH, Cheng AL, Lin JT and
Su IJ: Low-grade gastric B-cell lymphoma of mucosa-associated
lymphoid tissue: Clinicopathologic analysis of 19 cases. J Formos
Med Assoc. 95:857–65. 1996.PubMed/NCBI
|
|
30
|
Lehours P, Ruskone-Fourmestraux A,
Lavergne A, Cantet F and Mégraud F: Groupe d'Etude des Lymphomes
Digestifs (GELD) for the Fédération Française de Cancérologie
Digestive (FFCD). Which test to use to detect Helicobacter
pylori infection in patients with low-grade gastric
mucosa-associated lymphoid tissue lymphoma? Am J Gastroenterol.
98:291–295. 2003.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Bouzourene H, Haefliger T, Delacretaz F
and Saraga E: The role of Helicobacter pylori in primary
gastric MALT lymphoma. Histopathology. 34:118–123. 1999.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Draghici T, Negreanu L, Bratu OG, Pantea
Stoian A, Socea B, Neagu TP, Stanescu AMA, Manuc D and Diaconu CC:
Paraneoplastic syndromes in digestive tumors: A review. Rom Bio
Lett. 24:813–819. 2019.
|
|
33
|
Montalban C and Norman F: Treatment of
gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter
pylori eradication and beyond. Expert Rev Anticancer Ther.
6:361–371. 2006.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Diaconu C, Ioniță Radu F, Jinga M, Nuță P,
Bucurică S, Macadon B, Pătrășescu M, Popescu A, Balaban V, Voicu L,
et al: From liver biopsy to non-invasive markers in evaluating
fibrosis in chronic liver disease. Rom J Mil Med. 108:5–12.
2015.
|
|
35
|
Ion A, Popa IM, Papagheorghe LML,
Lisievici C, Lupu M, Voiculescu V, Caruntu C and Boda D: Proteomic
approaches to biomarker discovery in cutaneous T-cell lymphoma. Dis
Markers. 2016(9602472)2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
García M, Bellosillo B, Sánchez-González
B, García-Payarols F, Seoane A, Ferrer AM, Gimeno E, Barranco LE,
Torner A, Solé F, et al: Study of regulatory T-cells in patients
with gastric MALT lymphoma: influence on treatment response and
outcome. PLoS One. 7(e51681)2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Cioplea M, Caruntu C, Zurac S, Bastian A,
Sticlaru L, Cioroianu A, Boda D, Jugulete G, Nichita L and Popp C:
Dendritic cell distribution in mycosis fungoides vs. inflammatory
dermatosis and other T-cell skin lymphoma. Oncol Lett.
17:4055–4059. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Saito Y, Suzuki H, Tsugawa H, Imaeda H,
Matsuzaki J, Hirata K, Hosoe N, Nakamura M, Mukai M, Saito H and
Hibi T: Overexpression of miR-1425p and miR-155 in gastric
Mucosa-associated lymphoid tissue (MALT) lymphoma resistant to
Helicobacter pylori eradication. PLoS One.
7(e47396)2012.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Boda D: Cellomics as integrative omics for
cancer. Curr Proteomics. 10:237–245. 2013.
|
|
40
|
Nakamura M, Takahashi T, Matsui H,
Takahashi S, Murayama SY, Suzuki H and Tsuchimoto K: New
pharmaceutical treatment of gastric MALT lymphoma:
Anti-angiogenesis treatment using VEGF receptor antibodies and
celecoxib. Curr Pharm Des. 20:1097–1103. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Surcel M, Huica RI, Munteanu AN, Isvoranu
G, Pirvu IR, Ciotaru D, Constantin C, Bratu O, Caruntu C, Neagu M
and Ursaciuc C: Phenotypic changes of lymphocyte populations in
psoriasiform dermatitis animal model. Exp Ther Med. 17:1030–1038.
2019.PubMed/NCBI View Article : Google Scholar
|
